Fil Industries Private Limited
Fil Industries Private Limited is a Private Non-govt company company incorporated in 1989 and based in Jammu & Kashmir, India. Fil Industries Private Limited operates in Chemical substances used in the manufacture of anti-biotic, manufacturing (NIC 24231) with authorized capital of ₹22.75 Cr and paid-up capital of ₹16.01 Cr. For 2023-24, the company reported revenue of ₹337.69 Cr and profit after tax of ₹9.52 Cr. The board has 2 active directors. RegisterKaro's provisional Compliance Health Score for the company is 100/100 (grade A), based on 4 of 9 signals — full scoring is pending extraction of the company's MCA filing history.
Quick facts
Directors
2 activeMCA Filings
Locked| Form | FY | Filed | Due | Delay | Status |
|---|---|---|---|---|---|
| AOC-4 | FY2024-25 | 30 Oct 2024 | 30 Oct 2024 | +33d | filed |
| MGT-7 | FY2024-25 | 22 Nov 2024 | 29 Nov 2024 | 0d | filed |
| AOC-4 | FY2023-24 | 30 Oct 2023 | 30 Oct 2023 | 0d | filed |
| MGT-7 | FY2023-24 | 20 Nov 2023 | 29 Nov 2023 | 0d | filed |
| AOC-4 | FY2022-23 | 30 Oct 2022 | 30 Oct 2022 | +11d | filed |
| MGT-7 | FY2022-23 | 26 Nov 2022 | 29 Nov 2022 | 0d | filed |
Full MCA filing history for Fil Industries Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Charges
Locked| Charge ID | Holder | Amount | Created | Status |
|---|---|---|---|---|
| 245634677 | ICICI Bank Ltd(Bank) | ₹12.14 Cr | 04 Jul 2022 | Open |
| 335381617 | HDFC Bank Ltd(Bank) | ₹87.98 L | 27 Jan 2023 | Open |
| 821677901 | ICICI Bank Ltd(Bank) | ₹1.77 Cr | 04 Jul 2022 | Open |
| 540356501 | Axis Bank Ltd(Bank) | ₹8.92 Cr | 27 Jan 2023 | Open |
| 997889593 | HDFC Bank Ltd(Bank) | ₹13.92 Cr | 12 Mar 2020 | Open |
Charge IDs, lenders & amounts for Fil Industries Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Financial Performance
MCA| FY | Revenue | PAT | Net Worth | Total Assets | Employees |
|---|---|---|---|---|---|
| 2023-24 | — | ||||
| 2021-22 | — | ||||
| 2020-21 | — | ||||
| 2018-19 | — | ||||
| 2017-18 | — | ||||
| 2016-17 | — | ||||
| 2015-16 | — |
Detailed Financials
4 FYs| Line item | 2023-24 | 2021-22 | 2020-21 | 2018-19 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue from operations | ||||
| Other income | ||||
| Total income | ||||
| Total expenses | ||||
| Profit before tax | ||||
| Profit / (Loss) after tax | ||||
| Balance sheet | ||||
| Equity / Net worth | ||||
| Borrowings | ||||
| Current liabilities | ||||
| Total liabilities | ||||
| Current assets | ||||
| Cash & equivalents | ||||
| Total assets | ||||
| Employees | — | — | — | — |
Cash-flow statement renders when the AOC-4 XBRL Cash Flow context is parsed during the extract phase.
Compounded Annual Growth Rate
| Metric | Latest value | 1Y CAGR | 3Y CAGR | 5Y CAGR |
|---|---|---|---|---|
| Revenue2023-24 | +1.0% | +56.0% | +4.0% | |
| Profit after Tax2023-24 | -54.0% | -9.0% | -1.0% | |
| Net Worth2023-24 | -4.0% | +4.0% | +8.0% |
Financial Ratios
| FY | Revenue | PAT | PAT margin | Rev growth | ROE | ROA | D/E | Rev/emp |
|---|---|---|---|---|---|---|---|---|
| 2015-16 | +3.32% | — | +5.63% | +3.37% | — | |||
| 2016-17 | +3.55% | -2.39% | +5.55% | +3.35% | — | |||
| 2017-18 | +4.36% | -1.68% | +6.14% | +3.83% | — | |||
| 2018-19 | +4.68% | -6.15% | +5.87% | +3.36% | — | |||
| 2020-21 | +5.29% | +13.52% | +7.00% | +3.89% | — | |||
| 2021-22 | +4.97% | +9.95% | +6.78% | +3.59% | — | |||
| 2023-24 | +2.82% | +8.86% | +4.60% | +1.85% | — |
Cap Table & Shareholding
Locked| Category | Shareholders | Shares held | % |
|---|---|---|---|
| Promoters | 1 | 1,93,73,981 | 62.50% |
| Institutional Investors | 3 | 55,47,054 | 17.89% |
| Public & Others | 16 | 60,76,765 | 19.60% |
Promoter, institutional & public holding for Fil Industries Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Peer Benchmark
228 peersTop 10 in Chemical substances used in the manufacture of anti-biotic, manufacturing
by healthView all ›Events & timeline
3External data sources
7 plannedGSTIN Registrations
Per-state GSTINs + GSTR-1/3B filing cadence + turnover bracket. PAN-keyed scrape.
MSME Payment Delays
Half-yearly disclosure of payments delayed beyond 45 days to MSME suppliers.
Related Party Transactions
Counterparty, nature, transaction value. Inter-company loans, sales, royalty.
Credit Ratings
Long-term + short-term ratings, with rationale on rating actions.
Trademarks
Applied, registered, opposed. Class numbers + status.
Patents
Applications and grants. Inventor names + filing dates.
Legal Cases
Ongoing + past litigations the entity is party to.
Each source is wired as a separate ingestion adapter behind the scraper. Live status flips per CIN as records land.